Treatment with Pergolide or Cyproheptadine of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease)
Authors:
Open Access
- 1 November 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 16 (6) , 742-746
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolideEquine Veterinary Journal, 2002
- Plasma Adrenocorticotropin Concentration in Healthy Horses and in Horses With Clinical Signs of HyperadrenocorticismJournal of Veterinary Internal Medicine, 1996
- Laboratory diagnosis of equine pituitary pars intermedia adenomaDomestic Animal Endocrinology, 1995
- Diagnostic testing for pituitary pars intermedia dysfunction in horsesJournal of the American Veterinary Medical Association, 1994
- Insulin and glucose response following oral glucose administration in well‐conditioned poniesEquine Veterinary Journal, 1992
- Equine Cushing’s Disease: Differential Regulation of β-Endorphin Processing in Tumors of the Intermediate Pituitary*Endocrinology, 1988
- Equine intravenous glucose tolerance test: Glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenomaAmerican Journal of Veterinary Research, 1986
- Validation of a rapid solid-phase radioimmunoassay for canine, bovine, and equine insulinAmerican Journal of Veterinary Research, 1982
- Equine Cushing's Disease: Plasma Immunoreactive Proopiolipomelanocortin Peptide and Cortisol Levels Basally and in Response to Diagnostic Tests*Endocrinology, 1982